Unexpected distribution of the fluoroquinolone-resistance gene qnrB in Escherichia coli isolates from different human and poultry origins in Ecuador by Paulina I. Armas-Freire et al.
RESEARCH ARTICLE
International Microbiology (2015) 18:85-90
doi:10.2436/20.1501.01.237. ISSN (print): 1139-6709. e-ISSN: 1618-1095
www.im.microbios.org
Unexpected distribution of the fluoroquinolone-
resistance gene qnrB in Escherichia coli isolates 
from different human and poultry origins in Ecuador 
Paulina I. Armas-Freire,1 Gabriel Trueba,1* Carolina Proaño-Bolaños,1 Karen Levy,2 
Lixin Zhang,3,4 Carl F. Marrs,3 William Cevallos,5 Joseph N.S. Eisenberg3  
1Institute of Microbiology, Biological and Environmental Sciences College, University San Francisco de Quito, Quito, Ecuador. 2 Department of 
Environmental Health, Emory University, Atlanta, USA. 3Department of Epidemiology, University of Michigan, Ann Arbor, USA. 4Department of 
Epidemiology and Biostatistics, Michigan State University, East Lansing, USA. 5Institute of Biomedicine, Central University of Ecuador, Quito, Ecuador
 
Received 15 March 2015 · Accepted 3 June 2015
Summary. Fluoroquinolone resistance can be conferred through chromosomal mutations or by the acquisition of plasmids 
carrying genes such as the quinolone resistance gene (qnr). In this study, 3,309 strains of commensal Escherichia coli were 
isolated in Ecuador from: (i) humans and chickens in a rural northern coastal area (n = 2368, 71.5%) and (ii) chickens from an 
industrial poultry operation (n = 827, 25%). In addition, 114 fluoroquinolone-resistant strains from patients with urinary tract 
infections who were treated at three urban hospitals in Quito, Ecuador were analyzed. All of the isolates were subjected to 
antibiotic susceptibility screening. Fluoroquinolone-resistant isolates (FRIs) were then screened for the presence of qnrB genes. 
A significantly higher phenotypic resistance to fluoroquinolones was determined in E. coli strains from chickens in both the 
rural area (22%) and the industrial operation (10%) than in strains isolated from humans in the rural communities (3%). 
However, the rates of qnrB genes in E. coli isolates from healthy humans in the rural communities (11 of 35 isolates, 31%) was 
higher than in chickens from either the industrial operations (3 of 81 isolates, 6%) or the rural communities (7 of 251 isolates, 
2.8%). The occurrence of qnrB genes in human FRIs obtained from urban hospitals was low (1 of 114 isolates, 0.9%). These 
results suggested that the qnrB gene is more widely distributed in rural settings, where antibiotic usage is low, than in urban 
hospitals and industrial poultry operations. The role of qnrB in clinical resistance to fluoroquinolones is thus far unknown. [Int 
Microbiol 2015; 18(2):85-90]
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Introduction
 
Every year in the USA alone, more than two million people 
are infected with antibiotic-resistant bacteria, resulting in 
more than 23,000 deaths [3]. The antibiotic resistance of 
pathogens has been linked to both the medical and the agricul-
tural usage of antibiotics [6,7,15,16]. Resistance to fluoroqui-
nolones poses a particularly challenging health problem be-
cause these broad-spectrum antibiotics are used to treat seri-
ous bacterial infections, especially those acquired in hospitals 
[2,3,5]. Both the mutations in chromosomal genes [2] and the 
presence of conjugative or non-conjugative plasmids carrying 
the quinolone resistance gene qnr or other genes [10,21,27] 
have been implicated in fluoroquinolone resistance. Plasmid-
mediated quinolone resistance in human pathogens has been 
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associated with food-producing animals in some studies 
[8,28] but not in others [20]. 
Among the qnr genes, qnrB is widely distributed in South 
American countries [17,18,20]. In Ecuador, where there is no 
restriction on the use of fluoroquinolones in animal feed, the 
prevalence of fluoroquinolone resistance in community-ac-
quired Escherichia coli isolates from the human urinary tract 
is 41% [22]. In the present study, we assessed fluoroquinolone 
resistance and the presence of qnrB genes in E. coli isolates 
obtained in Ecuador from fecal samples collected from chick-
ens and humans in a rural, low antibiotic use setting and from 
two higher antibiotic use settings. Specifically, we compared 
fluoroquinolone-resistant isolates (FRIs) from (i) healthy hu-
mans living in rural communities, (ii) chickens (broiler and 
free-range) raised in rural communities, (iii) humans treated 
at urban hospitals, and (iv) chickens from an industrial poul-
try operation. 
Materials and methods
Samples and bacterial isolates. Escherichia coli was isolated from 
1,167 human fecal samples and 1,201 chicken cloacal swabs (from 1,134 
chickens) cultured on MacConkey agar. Five lactose-fermenting colonies 
were selected from each sample and tested for glucuronidase activity on 
Chromocult agar. Glucuronidase-positive colonies were subjected to antibi-
otic susceptibility testing. One FRI was selected from each sample. In these 
FRIs, an inhibition zone ≤ 20 mm was produced in response to discs contain-
ing 5 µg of ciprofloxacin. Kirby-Bauer antibiotic susceptibility testing was 
carried out in accordance with the guidelines of the Clinical and Laboratory 
Standards Institute [3b].
Isolates from chickens in rural communities. The 1,201 E. coli 
isolates were obtained between January and March 2009 from chickens 
raised in small-scale poultry farming operations in a rural community in 
northwestern Ecuador. The majority of these isolates (955; 80%) were from 
broiler chickens that had been purchased from a local distributor and fed with 
commercial poultry feed. Of these 955 isolates, 831 were from 30 chickens 
sampled weekly for 6 weeks at three farms in one community and 124 were 
from 25 chickens sampled once cross-sectionally at another farm in the same 
community. An additional 246 (20%) isolates were obtained from household 
varietals (other breeds of chickens also purchased from a local distributor). 
Isolates from all chickens in the rural communities were labeled RemCHK. 
In addition, one isolate (Rem6) was obtained from water drawn from a well 
in the same community as the chickens.
Isolates from humans in rural communities. The 1,167 com-
mensal E. coli isolates were obtained from healthy humans (controls) resid-
ing in 24 communities in northwestern Ecuador who participated in a case-
control study of diarrheal diseases between February 2009 and February 
2010. Details about the region, study design, and sampling strategy were de-
scribed previously [4]. The human isolates were labeled RemHUM. All inter-
actions with human subjects were approved by the University of Michigan’s 
Institutional Review Board and the Universidad San Francisco de Quito’s 
Bioethics Committee.
Isolates from chickens in an industrial operation. The 827 E. coli 
isolates from an industrial poultry operation (located on the Ecuadorian coast, 
~300 km from the study region) were obtained from broiler chickens sampled 
between March and November 2010. These animals had been kept in coops 
and received oxytetracycline (10 mg/l) in their drinking water. These isolates 
were labeled IndCHK.
Isolates from humans in urban hospitals. The 114 clinical FRIs 
were isolated from patients with E. coli urinary tract infections who were 
seen at three hospitals in urban Quito from May to July 2010. Of these iso-
lates, 61 were from Hospital Vozandes (kindly provided by Jeannette Zurita), 
42 were from Hospital Carlos Andrade Marín (kindly provided by Isabel 
Narváez), and 11 were from the Institute of Microbiology at the Universidad 
San Francisco de Quito. These clinical human isolates were labeled E. coli 
Quito Hospital.
Table 1. Nucleotide sequences of qnrB genes from fluoroquinolone 
resistance isolates (FRIs) of Escherichia coli from humans and chickens 
inhabiting rural communities located on the northern coast of Ecuador, 
from chickens from an industrial operation, and from humans treated at an 
urban hospital in Quito
Amplicon GenBank accession number 
RemHUM1 JN714812
RemHUM2 JN714813
RemHUM3 JN714814
RemHUM4 JN714815
RemHUM5 JN714816
RemCHK6 JN714817
RemCHK7 JN714818
RemCHK8 JN714819
RemCHK9 JN714820
RemCHK10 JN714821
RemCHK11 JN714822
RemCHK12 JN714823
RemCHK13 JN714824
RemCHK14 JN714825
RemCHK15 JN714826
RemCHK17 JN714828
RemCHK18 JN714829
RemCHK19 JN714830
RemCHK20 JN714831
RemCHK21 JN714832
RemCHK22 JN714833
RemCHK23 JN714834
IndCHK24 JN714835
IndCHK25 JN714836
IndCHK26 JN714837
Quito Hospital JN714838
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Fig. 1. Maximum likelihood analysis of qnrB genes in Escherichia coli isolates. RemHUM: bacterial sequences 
obtained from humans in Ecuadorian rural communities. RemCHK: sequences from chickens in rural communities. 
E. coli Quito Hospital: qnrB from hospital isolates in Quito, Ecuador. IndCHK: sequences from isolates from a poultry 
industrial operation. The remaining sequences were obtained from GenBank: E.coli strain F84, accession number 
KM094204.1; E. coli strain F257 accession number KM094205.1; E. coli strain ECH8, accession number KP268825.1; 
Haemophilus parasuis strain SC056, accession number HQ117877.1. Numbers are bootstrap values obtained after 500 
pseudoreplicates. Asterisk indicates sequences analyzed in the present work. 
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Polymerase chain reaction amplification and DNA se-
quence analysis. Bacterial DNA from a single FRI colony was extracted 
from the cells using a boiling technique [25]. A PCR for qnrB genes was 
carried out following the method described in [8] and using the following 
primers to amplify internal fragments of the target gene: qnrB F 5′-GG-
MATHGAAATTCGCCACTG-3′ and qnrB R 5′-TTTGCYGYYCGC-
CAGTCGAA-3′. The PCR conditions were as follows: 95°C for 5 min, 35 
cycles of 94°C for 30 s, 56°C for 40 s and 72°C for 1 min, and a final incu-
bation at 72°C for 10 min. Amplicons were sequenced by the University of 
Michigan DNA Sequencing Core. The qnrB gene sequences described in 
this report were deposited under the accession numbers JN714812 to 
JN714838 (Table 1). A subset of these amplicons (IndCHK24, IndCHK25, 
IndCHK26. and E. coli Quito Hospital) were sequenced a second time at 
Functional Biosciences, Inc. (Madison, WI) to rule out errors. They were 
used in the phylogenetic analysis, performed with the Mega5.1 program 
(Fig. 1). Two qnrB sequences from the FRIs of broiler chicken came from 
the same animal, from two colonies collected 2 weeks apart (RemCHKb7 
and RemCHKb9).
Statistical analysis. A c2 test was used to analyze the differences 
in fluoroquinolone resistance and qnrB gene frequency between sample 
types. 
Results and Discussion 
Rates of resistance. The rates of fluoroquinolone resis-
tance were significantly higher (P < 0.001) in isolates from 
chickens in rural communities (broilers: 214 of 961 isolates; 
household varietals: 37 of 246 isolates) than in isolates from 
chickens raised in industrial operations (81of 827 isolates) or 
in isolates from humans living in rural communities (35 of 
1,167 isolates) (Table 2).
Presence of qnrB gene in fluoroquinolone-re-
sistant isolates. The percentage of human FRIs carrying 
qnrB genes differed subtantially, depending on the origin of 
the isolates: 31.4% (11 of 35 isolates) of the human FRIs from 
rural communities carried the qnrB gene vs. 0.88% (1 of 114 
isolates) of those from hospitals in Quito (P < 0.0001) (Table 
2). The differences among the chicken isolates were smaller: 
1.87% (4 of 214 isolates) of the FRIs from broiler chickens in 
rural communities 8.1% (3 of 37 isolates) of those from 
household varietals, and 6% (3 of 50 isolates analized) of 
those from broiler chickens raised in industrial operations 
(P = 0.4). The differences between FRIs from broiler chickens 
and household varietals in the rural community were not sig-
nificant (P = 0.069). 
Phylogenetic analysis of qnrB genes. The nucleo-
tide sequences of all the amplicons showed high similarities 
to previously described qnrB genes (Fig. 1). 
Conclusions. Based on the published literature [1] and the 
high prevalence of fluoroquinolone resistance previously re-
ported in Ecuador [22], a higher frequency of qnrB genes was 
expected from pathogenic FRIs from hospitals in Quito, 
where antibiotic use is high, than in rural settings, where anti-
biotic use is low. However, a high proportion of commensal E. 
coli isolated from humans in rural communities carried qnrB 
genes. Conversely, despite the high prevalence of FRIs ob-
tained from chickens raised in rural communities, the propor-
tion carrying qnrB genes was low. FRI from urban hospitals in 
Quito, where antibiotic use is high, had the lowest proportion 
Table 2. Fluoroquinolone resistance isolates (FRIs) of Escherichia coli with and without the qnrB gene. Five E. coli isolates were analyzed from 
each fecal sample obtained from either humans or chickens inhabiting rural communities located on the northern coast of Ecuador
Source of the isolate Number of isolates FRIs (%) FRIs with qnrB (%) P-value
Human isolates from a rural area 1,167 35 (2.9%) 11(31.4%)
Human isolates from urban hospitals NDa 114 1(0.88%) P < 0.0001c
Isolates from broiler chickens in a rural area 955 214 (22.4%) 4(1.87%)
Household varietals from a rural area 246 37 (15.4%) 3 (8.1%)
Isolates from broiler chickens from an industrial poultry 
operation
827  81 (9.8%)b 3 (6.0%)b
aND = Not determined.
bOut of 81 isolates, only 50 were analyzed for qnrB genes. 
cP-value obtained from a comparison of fluoroquinolone resistant human isolates from the rural community and from the hospital in Quito. 
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of qnrB gene carriage. Although qnr genes cause low-level 
resistance to quinolones [9], they are thought to be important 
in the development of the highly resistant phenotype [14]. 
The lack of association of the qnrB gene with clinical fluoro-
quinolone reistance in this study was therefore unexpected.
Other studies have found that qnrB genes are widely dis-
tributed in commensal E. coli isolated from healthy humans, 
including children, living in urban settings in Peru and Bo-
livia [17,18], from humans in remote Peruvian Amazon com-
munities [19], and from domestic and farm animals in Ger-
many [23]. In our study, healthy humans from rural, but not 
urban areas of Ecuador had high rates of qnrB carriage. We 
also found that although chickens had high rates of fluoroqui-
nolone resistance, the rates of qnrB carriage in the FRIs from 
these animals were low.
Although our findings suggest that qnrB genes are not 
linked to fluoroquinolone clinical resistance, they have been 
associated with the development of high resistance to quino-
lones [14,24]. Moreover, qnrB genes are one of the most com-
mon plasmid-mediated quinolone resistance genes [13]. The 
presence of qnrB genes in isolates from domestic animals is 
also a matter of concern, as these genes have been detected in 
food pathogens such as Salmonella [11]. The main limitation 
of this study was the amplified segment of DNA, which did 
not allow us to determine the diversity of the qnr genes. These 
and other studies on the role of qnr genes in fluoroquinolone 
resistance are needed. 
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